ContraVir Pharmaceuticals Reaches Agreement with the FDA on the NDA Package for TXL™ Leveraging the 505(b)(2) Regulatory Pathway

World News: . []

EDISON NJ Feb 12 2018 GLOBE NEWSWIRE -- ContraVir Pharmaceuticals Inc NASDAQCTRV a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies announced today that the US Food and Dru g Admin...

More news and information about ContraVir Pharmaceuticals Inc

Published By:

Globe Newswire: 11:00 GMT Monday 12th February 2018

Published: .

Search for other references to "contravir" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us